跳至主要内容
MedPath Trial logoMedPath TrialMedPath Trial Home
临床试验/JPRN-jRCT2080221866
JPRN-jRCT2080221866未知3 期

A Long-Term Follow-up Study of Subjects Who Participated in A Clinical Trial in Which Asunaprevir (BMS-650032) and/or Daclatasvir (BMS-790052) Was Administered for the Treatment of Chronic Hepatitis C

Bristol-Myers Squibb K.K.0 个研究点目标入组 1,000 人开始时间: 2012年7月26日最近更新:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
适应症

试验速览

阶段
3 期
入组人数
1,000
研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
>= 18age old 至 ot applicable（—）
性别
All

入选标准

  • •Subjects must have received at least one dose of BMS-650032 and/or BMS-790052 and completed participation in a previous study
  • •- Must enroll in this study within 6 months of completing previous BMS study or within 6 months of protocol availability

排除标准

  • •- Subject must not have been treated with any antiviral or immunomodulatory drug for CHC after completion of the previous study
  • •- Subject must not be participating in any other trial, xcluding non-interventional trials

研究者

相似试验

进行中（未招募）
1 期
Three-year Follow-up Study of Subjects Who Participated in a Previous Asunaprevir (BMS-650032) and/or Daclatasvir (BMS-790052) Chronic Hepatitis C Clinical Trial
EUCTR2011-005287-21-SEBristol-Myers Squibb International Corporation1,000
进行中（未招募）
1 期
Three-year Follow-up Study of Subjects Who Participated in a Previous BMS-650032 or BMS-790052 Chronic Hepatitis C Clinical Trial
EUCTR2011-005287-21-ITBRISTOL-MYERS SQUIBB INTERNATIONAL CORPORATIO1,000
进行中（未招募）
1 期
Three-year Follow-up Study of Subjects Who Participated in a Previous Asunaprevir (BMS-650032) and/or Daclatasvir (BMS-790052) Chronic Hepatitis C Clinical Trial
EUCTR2011-005287-21-IEBristol-Myers Squibb International Corporation1,000
进行中（未招募）
1 期
Three-year Follow-up Study of Subjects Who Participated in a Previous Asunaprevir (BMS-650032) and/or Daclatasvir (BMS-790052) Chronic Hepatitis C Clinical Trial
EUCTR2011-005287-21-GBBristol-Myers Squibb International Corporation1,000
进行中（未招募）
1 期
Three-year Follow-up Study of Subjects Who Participated in a Previous Asunaprevir (BMS-650032) and/or Daclatasvir (BMS-790052) Chronic Hepatitis C Clinical TrialChronic Hepatitis CMedDRA version: 14.1Level: LLTClassification code 10008912Term: Chronic hepatitis CSystem Organ Class: 10021881 - Infections and infestations
EUCTR2011-005287-21-ESBristol-Myers Squibb International Corporation1,000
A Long-Term Follow-up Study of Subjects Who... | 临床试验